Roche Holding AG
π¨πSwitzerland
- Country
- π¨πSwitzerland
- Ownership
- Public
- Established
- 1896-01-15
- Employees
- 103.6K
- Market Cap
- $270.5B
- Website
- http://www.roche.com
A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-03-17
- Last Posted Date
- 2016-05-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 67
- Registration Number
- NCT00303485
A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid Arthritis
- First Posted Date
- 2006-03-17
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 204
- Registration Number
- NCT00303563
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections
- First Posted Date
- 2006-03-17
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 313
- Registration Number
- NCT00303589
IMPACT Study: A Study of Valcyte (Valganciclovir) for Prevention of Cytomegalovirus Disease (CMV) in Kidney Allograft Recipients
- First Posted Date
- 2006-02-22
- Last Posted Date
- 2018-03-29
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 326
- Registration Number
- NCT00294515
- Locations
- πΊπΈ
UCLA Medical Center, Los Angeles, California, United States
πΊπΈRobert Wood Johnson Uni Hospital; Anesthesia, New Brunswick, New Jersey, United States
πΊπΈHackensack University Medical Center, Hackensack, New Jersey, United States
Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-01-25
- Last Posted Date
- 2013-09-19
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 817
- Registration Number
- NCT00281918
- Locations
- π©πͺ
Praxis Fur Hamatologie und Onkologie Ahaus, Ahaus, Germany
π©πͺHamatologische/Onkologische Gemeinschaftspraxis - Augsburg, Augsburg, Germany
π©πͺOnkologische Schwerpunktpraxis Bielefeld, Bielefeld, Germany
A Study of MabThera (Rituximab) in Patients With Advanced Non-Hodgkin's Lymphoma
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-12-23
- Last Posted Date
- 2015-07-23
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 360
- Registration Number
- NCT00269113
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-12-16
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 220
- Registration Number
- NCT00266253
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
- First Posted Date
- 2005-12-16
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 267
- Registration Number
- NCT00266240
WAND Study - A Study to Evaluate Fuzeon (Enfuvirtide) Administered by a Needle-Free Injection Device in Patients With HIV.
- First Posted Date
- 2005-10-06
- Last Posted Date
- 2015-11-03
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 58
- Registration Number
- NCT00233883
QUALITE Study - A Study of Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With Human Immunodeficiency Virus-1 (HIV-1) Infection
- First Posted Date
- 2005-10-05
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 361
- Registration Number
- NCT00232908
Β© Copyright 2024. All Rights Reserved by MedPath